Anthony Casarez
9Patents
3h-index
31Co-inventors
53Inventor score
Filing activity: Jul 6, 2007 → Sep 28, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7893264B2 | Antiviral phosphinate compounds | Human Necessities | 13 | Active |
| US8476225B2 | Antiviral compounds | Human Necessities | 6 | Active |
| US9174978B2 | Monobactam organic compounds for the treatment of bacterial infections | Emerging Cross-Sectional Technologies | 4 | Active |
| US10369138B2 | Monobactam organic compounds for the treatment of bacterial infections | Emerging Cross-Sectional Technologies | 2 | Active |
| US10065957B2 | Beta-lactamase inhibitors | Emerging Cross-Sectional Technologies | 1 | Active |
| US10597396B2 | Beta-lactamase inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US10919887B2 | Salts and solid forms of a monobactam antibiotic | Emerging Cross-Sectional Technologies | 0 | Active |
| US8586744B2 | Antiviral phosphinate compounds | Human Necessities | 0 | Active |
| US8674088B2 | Antiviral phosphinate compounds | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.